Type I interferons in infectious disease (original) (raw)

• Pestka, S., Krause, C. D. & Walter, M. R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8–32 (2004).
  CAS PubMed Google Scholar
• Schoenborn, J. R. & Wilson, C. B. Regulation of interferon-γ during innate and adaptive immune responses. Adv. Immunol. 96, 41–101 (2007).
  CAS PubMed Google Scholar
• O'Brien, T. R., Prokunina-Olsson, L. & Donnelly, R. P. IFN-λ4: the paradoxical new member of the interferon λ family. J. Interferon Cytokine Res. 34, 829–838 (2014).
  CAS PubMed PubMed Central Google Scholar
• Prokunina-Olsson, L. et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nature Genet. 45, 164–171 (2013).
  CAS PubMed Google Scholar
• Witte, K., Witte, E., Sabat, R. & Wolk, K. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev. 21, 237–251 (2010).
  CAS PubMed Google Scholar
• Durbin, R. K., Kotenko, S. V. & Durbin, J. E. Interferon induction and function at the mucosal surface. Immunol. Rev. 255, 25–39 (2013).
  PubMed PubMed Central Google Scholar
• Yan, N. & Chen, Z. J. Intrinsic antiviral immunity. Nature Immunol. 13, 214–222 (2012).
  CAS Google Scholar
• Goubau, D., Deddouche, S. & Reis e Sousa, C. Cytosolic sensing of viruses. Immunity 38, 855–869 (2013).
  CAS PubMed Google Scholar
• Paludan, S. R. & Bowie, A. G. Immune sensing of DNA. Immunity 38, 870–880 (2013).
  CAS PubMed PubMed Central Google Scholar
• Leber, J. H. et al. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 4, e6 (2008).
  PubMed PubMed Central Google Scholar
• Pandey, A. K. et al. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5, e1000500 (2009).
  PubMed PubMed Central Google Scholar
• Watanabe, T. et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Invest. 120, 1645–1662 (2010).
  CAS PubMed PubMed Central Google Scholar
• Moreira, L. O. & Zamboni, D. S. NOD1 and NOD2 signaling in infection and inflammation. Front. Immunol. 3, 328 (2012).
  PubMed PubMed Central Google Scholar
• Moynagh, P. N. TLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway. Trends Immunol. 26, 469–476 (2005).
  CAS PubMed Google Scholar
• Honda, K., Takaoka, A. & Taniguchi, T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349–360 (2006).
  CAS PubMed Google Scholar
• Tamura, T., Yanai, H., Savitsky, D. & Taniguchi, T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535–584 (2008).
  CAS PubMed Google Scholar
• Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nature Rev. Immunol. 14, 36–49 (2014). This review is a perfect prelude to the present review and describes the molecular mechanisms of regulation of type I IFNs in more detail.
  CAS Google Scholar
• Rauch, I., Muller, M. & Decker, T. The regulation of inflammation by interferons and their STATs. JAKSTAT 2, e23820 (2013).
  PubMed PubMed Central Google Scholar
• Versteeg, G. A. & Garcia-Sastre, A. Viral tricks to grid-lock the type I interferon system. Curr. Opin. Microbiol. 13, 508–516 (2010).
  CAS PubMed PubMed Central Google Scholar
• McNab, F. W., Rajsbaum, R., Stoye, J. P. & O'Garra, A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 23, 46–56 (2011).
  CAS PubMed Google Scholar
• Diamond, M. S. & Schoggins, J. W. Host restriction factor screening: let the virus do the work. Cell Host Microbe 14, 229–231 (2013).
  CAS PubMed Google Scholar
• Muller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918–1921 (1994).
  CAS PubMed Google Scholar
• Haller, O., Arnheiter, H., Gresser, I. & Lindenmann, J. Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J. Exp. Med. 154, 199–203 (1981).
  CAS PubMed Google Scholar
• Durbin, J. E. et al. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164, 4220–4228 (2000).
  CAS PubMed Google Scholar
• Garcia-Sastre, A. et al. The role of interferon in influenza virus tissue tropism. J. Virol. 72, 8550–8558 (1998).
  CAS PubMed PubMed Central Google Scholar
• Koerner, I., Kochs, G., Kalinke, U., Weiss, S. & Staeheli, P. Protective role of β interferon in host defense against influenza A virus. J. Virol. 81, 2025–2030 (2007).
  CAS PubMed Google Scholar
• Price, G. E., Gaszewska-Mastarlarz, A. & Moskophidis, D. The role of α/β and γ interferons in development of immunity to influenza A virus in mice. J. Virol. 74, 3996–4003 (2000).
  CAS PubMed PubMed Central Google Scholar
• Mordstein, M. et al. λ Interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84, 5670–5677 (2010).
  CAS PubMed PubMed Central Google Scholar
• Mordstein, M. et al. Interferon-λ contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4, e1000151 (2008). This study demonstrates the redundant roles of type I and type III IFNs in the anti-influenza virus response, clarifying the confusion arising from earlier literature that reported that type I IFNs cannot account for the requirement for STAT1 signalling in protection against influenza virus infection.
  PubMed PubMed Central Google Scholar
• Crotta, S. et al. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog. 9, e1003773 (2013). This study demonstrates the redundant roles of type I and type III IFN signalling in epithelial cells in the anti-influenza virus response, clarifying the confusion arising from earlier literature over protection against influenza virus infection.
  PubMed PubMed Central Google Scholar
• Casanova, J. L., Holland, S. M. & Notarangelo, L. D. Inborn errors of human JAKs and STATs. Immunity 36, 515–528 (2012).
  CAS PubMed PubMed Central Google Scholar
• Zhang, S. Y. et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-α/β, IFN-γ, and IFN-λ in host defense. Immunol. Rev. 226, 29–40 (2008).
  CAS PubMed Google Scholar
• Suppiah, V. et al. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy. Nature Genet. 41, 1100–1104 (2009).
  CAS PubMed Google Scholar
• Tanaka, Y. et al. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C. Nature Genet. 41, 1105–1109 (2009).
  CAS PubMed Google Scholar
• Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399–401 (2009).
  CAS PubMed Google Scholar
• Thomas, D. L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798–801 (2009).
  CAS PubMed PubMed Central Google Scholar
• Sandler, N. G. et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601–605 (2014).
  CAS PubMed PubMed Central Google Scholar
• Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519–523 (2012). This study provided the first evidence of host genetics ( IFITM3 ) contributing to susceptibility to influenza virus infection in humans.
  CAS PubMed PubMed Central Google Scholar
• Zhang, Y. H. et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nature Commun. 4, 1418 (2013). This is a follow-up study to reference 38, showing that IFITM3 variants that contribute to the severity of influenza virus infection are predominant in the Chinese population.
  Google Scholar
• Staeheli, P., Grob, R., Meier, E., Sutcliffe, J. G. & Haller, O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8, 4518–4523 (1988).
  CAS PubMed PubMed Central Google Scholar
• Horisberger, M. A., Staeheli, P. & Haller, O. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl Acad. Sci. USA 80, 1910–1914 (1983).
  CAS PubMed Google Scholar
• Horby, P., Nguyen, N. Y., Dunstan, S. J. & Baillie, J. K. The role of host genetics in susceptibility to influenza: a systematic review. PLoS ONE 7, e33180 (2012).
  CAS PubMed PubMed Central Google Scholar
• Dauer, M. et al. Interferon-α disables dendritic cell precursors: dendritic cells derived from interferon-α-treated monocytes are defective in maturation and T-cell stimulation. Immunology 110, 38–47 (2003).
  CAS PubMed PubMed Central Google Scholar
• Lapenta, C. et al. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-α. J. Exp. Med. 198, 361–367 (2003).
  CAS PubMed PubMed Central Google Scholar
• Santini, S. M. et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191, 1777–1788 (2000).
  CAS PubMed PubMed Central Google Scholar
• Santodonato, L. et al. Monocyte-derived dendritic cells generated after a short-term culture with IFN-α and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response. J. Immunol. 170, 5195–5202 (2003).
  CAS PubMed Google Scholar
• Hahm, B., Trifilo, M. J., Zuniga, E. I. & Oldstone, M. B. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22, 247–257 (2005).
  CAS PubMed Google Scholar
• Ito, T. et al. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166, 2961–2969 (2001).
  CAS PubMed Google Scholar
• Montoya, M. et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99, 3263–3271 (2002).
  CAS PubMed Google Scholar
• Le Bon, A. et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nature Immunol. 4, 1009–1015 (2003).
  CAS Google Scholar
• Le Bon, A. et al. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J. Immunol. 176, 4682–4689 (2006).
  CAS PubMed Google Scholar
• Spadaro, F. et al. IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing. Blood 119, 1407–1417 (2012).
  CAS PubMed Google Scholar
• Parlato, S. et al. Expression of CCR-7, MIP-3β, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 98, 3022–3029 (2001).
  CAS PubMed Google Scholar
• Rouzaut, A. et al. Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-α. Eur. J. Immunol. 40, 3054–3063 (2010).
  CAS PubMed Google Scholar
• Gautier, G. et al. A type I interferon autocrine–paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 201, 1435–1446 (2005).
  CAS PubMed PubMed Central Google Scholar
• Cousens, L. P., Orange, J. S., Su, H. C. & Biron, C. A. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl Acad. Sci. USA 94, 634–639 (1997).
  CAS PubMed Google Scholar
• Dalod, M. et al. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195, 517–528 (2002).
  CAS PubMed PubMed Central Google Scholar
• Orange, J. S., Wolf, S. F. & Biron, C. A. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152, 1253–1264 (1994).
  CAS PubMed Google Scholar
• Orange, J. S. et al. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181, 901–914 (1995).
  CAS PubMed Google Scholar
• Le Bon, A. et al. Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176, 2074–2078 (2006).
  CAS PubMed Google Scholar
• Havenar-Daughton, C., Kolumam, G. A. & Murali-Krishna, K. The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 176, 3315–3319 (2006).
  CAS PubMed Google Scholar
• Brinkmann, V., Geiger, T., Alkan, S. & Heusser, C. H. Interferon α increases the frequency of interferon γ-producing human CD4+ T cells. J. Exp. Med. 178, 1655–1663 (1993).
  CAS PubMed Google Scholar
• Hofer, M. J. et al. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus. J. Virol. 86, 6932–6946 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lazear, H. M., Pinto, A. K., Vogt, M. R., Gale, M. Jr & Diamond, M. S. β-Interferon controls West Nile virus infection and pathogenesis in mice. J. Virol. 85, 7186–7194 (2011).
  CAS PubMed PubMed Central Google Scholar
• Shiow, L. R. et al. CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440, 540–544 (2006).
  CAS PubMed Google Scholar
• Petricoin, E. F. et al. Antiproliferative action of interferon-α requires components of T-cell-receptor signalling. Nature 390, 629–632 (1997).
  CAS PubMed Google Scholar
• Kaser, A., Nagata, S. & Tilg, H. Interferon α augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Cytokine 11, 736–743 (1999).
  CAS PubMed Google Scholar
• Marshall, H. D., Urban, S. L. & Welsh, R. M. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J. Virol. 85, 5929–5939 (2011).
  CAS PubMed PubMed Central Google Scholar
• Bromberg, J. F., Horvath, C. M., Wen, Z., Schreiber, R. D. & Darnell, J. E. Jr. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ. Proc. Natl. Acad. Sci. USA 93, 7673–7678 (1996).
  CAS PubMed Google Scholar
• Lee, C. K., Smith, E., Gimeno, R., Gertner, R. & Levy, D. E. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ. J. Immunol. 164, 1286–1292 (2000).
  CAS PubMed Google Scholar
• Tanabe, Y. et al. Role of STAT1, STAT3, and STAT5 in IFN-α/β responses in T lymphocytes. J. Immunol. 174, 609–613 (2005).
  CAS PubMed Google Scholar
• Marrack, P., Kappler, J. & Mitchell, T. Type I interferons keep activated T cells alive. J. Exp. Med. 189, 521–530 (1999).
  CAS PubMed PubMed Central Google Scholar
• Aichele, P. et al. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J. Immunol. 176, 4525–4529 (2006).
  CAS PubMed Google Scholar
• Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. & Murali-Krishna, K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202, 637–650 (2005).
  CAS PubMed PubMed Central Google Scholar
• Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D. & Mescher, M. F. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174, 4465–4469 (2005).
  CAS PubMed Google Scholar
• Keppler, S. J., Rosenits, K., Koegl, T., Vucikuja, S. & Aichele, P. Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses. PLoS ONE 7, e40865 (2012).
  CAS PubMed PubMed Central Google Scholar
• Gimeno, R., Lee, C. K., Schindler, C. & Levy, D. E. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by α/β interferon in T lymphocytes. Mol. Cell. Biol. 25, 5456–5465 (2005).
  CAS PubMed PubMed Central Google Scholar
• Gil, M. P., Salomon, R., Louten, J. & Biron, C. A. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 107, 987–993 (2006).
  CAS PubMed PubMed Central Google Scholar
• Agarwal, P. et al. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J. Immunol. 183, 1695–1704 (2009).
  CAS PubMed PubMed Central Google Scholar
• Marshall, H. D., Prince, A. L., Berg, L. J. & Welsh, R. M. IFN-α/β and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J. Immunol. 185, 1419–1428 (2010).
  CAS PubMed PubMed Central Google Scholar
• Cousens, L. P. et al. Two roads diverged: interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection. J. Exp. Med. 189, 1315–1328 (1999).
  CAS PubMed PubMed Central Google Scholar
• Nguyen, K. B. et al. Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection. Science 297, 2063–2066 (2002).
  CAS PubMed Google Scholar
• Nguyen, K. B. et al. Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox. Nature Immunol. 1, 70–76 (2000).
  CAS Google Scholar
• Thompson, L. J., Kolumam, G. A., Thomas, S. & Murali-Krishna, K. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 177, 1746–1754 (2006).
  CAS PubMed Google Scholar
• Pinto, A. K. et al. A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection. PLoS Pathog. 7, e1002407 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ramos, H. J. et al. Reciprocal responsiveness to interleukin-12 and interferon-α specifies human CD8+ effector versus central memory T-cell fates. Blood 113, 5516–5525 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kohlmeier, J. E., Cookenham, T., Roberts, A. D., Miller, S. C. & Woodland, D. L. Type I interferons regulate cytolytic activity of memory CD8+ T cells in the lung airways during respiratory virus challenge. Immunity 33, 96–105 (2010).
  CAS PubMed PubMed Central Google Scholar
• Sung, J. H. et al. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 150, 1249–1263 (2012).
  CAS PubMed PubMed Central Google Scholar
• Soudja, S. M., Ruiz, A. L., Marie, J. C. & Lauvau, G. Inflammatory monocytes activate memory CD8+ T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37, 549–562 (2012).
  CAS PubMed PubMed Central Google Scholar
• Crouse, J. et al. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity 40, 961–973 (2014).
  CAS PubMed Google Scholar
• Xu, H. C. et al. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity 40, 949–960 (2014).
  CAS PubMed Google Scholar
• Hwang, I. et al. Activation mechanisms of natural killer cells during influenza virus infection. PLoS ONE 7, e51858 (2012).
  CAS PubMed PubMed Central Google Scholar
• Martinez, J., Huang, X. & Yang, Y. Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J. Immunol. 180, 1592–1597 (2008).
  CAS PubMed Google Scholar
• Nguyen, K. B. et al. Coordinated and distinct roles for IFN-α/β, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169, 4279–4287 (2002).
  CAS PubMed Google Scholar
• Lucas, M., Schachterle, W., Oberle, K., Aichele, P. & Diefenbach, A. Dendritic cells prime natural killer cells by _trans_-presenting interleukin 15. Immunity 26, 503–517 (2007).
  CAS PubMed PubMed Central Google Scholar
• Sun, J. C., Ma, A. & Lanier, L. L. IL-15-independent NK cell response to mouse cytomegalovirus infection. J. Immunol. 183, 2911–2914 (2009).
  CAS PubMed PubMed Central Google Scholar
• Baranek, T. et al. Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe 12, 571–584 (2012).
  CAS PubMed Google Scholar
• Miyagi, T. et al. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J. Exp. Med. 204, 2383–2396 (2007).
  CAS PubMed PubMed Central Google Scholar
• Mack, E. A., Kallal, L. E., Demers, D. A. & Biron, C. A. Type 1 interferon induction of natural killer cell γ interferon production for defense during lymphocytic choriomeningitis virus infection. MBio 2, e00169-11 (2011).
  PubMed PubMed Central Google Scholar
• Wang, J., Lin, Q., Langston, H. & Cooper, M. D. Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity 3, 475–484 (1995).
  CAS PubMed Google Scholar
• Lin, Q., Dong, C. & Cooper, M. D. Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med. 187, 79–87 (1998).
  CAS PubMed PubMed Central Google Scholar
• Bosio, E., Cluning, C. L. & Beilharz, M. W. Low-dose orally administered type I interferon reduces splenic B cell numbers in mice. J. Interferon Cytokine Res. 21, 721–728 (2001).
  CAS PubMed Google Scholar
• Le Bon, A. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461–470 (2001).
  CAS PubMed Google Scholar
• Swanson, C. L. et al. Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J. Exp. Med. 207, 1485–1500 (2010).
  CAS PubMed PubMed Central Google Scholar
• Coro, E. S., Chang, W. L. & Baumgarth, N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J. Immunol. 176, 4343–4351 (2006).
  CAS PubMed Google Scholar
• Chang, W. L. et al. Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J. Immunol. 178, 1457–1467 (2007).
  CAS PubMed Google Scholar
• Rau, F. C., Dieter, J., Luo, Z., Priest, S. O. & Baumgarth, N. B7-1/2 (CD80/CD86) direct signaling to B cells enhances IgG secretion. J. Immunol. 183, 7661–7671 (2009).
  CAS PubMed PubMed Central Google Scholar
• Heer, A. K. et al. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178, 2182–2191 (2007).
  CAS PubMed Google Scholar
• Fink, K. et al. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses. Eur. J. Immunol. 36, 2094–2105 (2006).
  CAS PubMed Google Scholar
• Bach, P. et al. Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies. J. Immunol. 178, 5839–5847 (2007).
  CAS PubMed Google Scholar
• Purtha, W. E., Chachu, K. A., Virgin, H. W. & Diamond, M. S. Early B-cell activation after West Nile virus infection requires α/β interferon but not antigen receptor signaling. J. Virol. 82, 10964–10974 (2008).
  CAS PubMed PubMed Central Google Scholar
• Moseman, E. A. et al. B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity. Immunity 36, 415–426 (2012).
  CAS PubMed PubMed Central Google Scholar
• Biron, C. A. Interferons α and β as immune regulators — a new look. Immunity 14, 661–664 (2001).
  CAS PubMed Google Scholar
• Davidson, S., Crotta, S., McCabe, T. M. & Wack, A. Pathogenic potential of interferon αβ in acute influenza infection. Nature Commun. 5, 3864 (2014). This seminal publication shows that, in contrast to the dogma, type I IFNs can cause morbidity and mortality, as opposed to protection, during influenza virus infection.
  CAS Google Scholar
• Mandl, J. N. et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nature Med. 14, 1077–1087 (2008).
  CAS PubMed Google Scholar
• Jacquelin, B. et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. 119, 3544–3555 (2009).
  CAS PubMed PubMed Central Google Scholar
• Rotger, M. et al. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J. Clin. Invest. 121, 2391–2400 (2011).
  CAS PubMed PubMed Central Google Scholar
• McNally, J. M. et al. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75, 5965–5976 (2001).
  CAS PubMed PubMed Central Google Scholar
• Chi, B. et al. α and λ interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J. Virol. 80, 5032–5040 (2006).
  CAS PubMed PubMed Central Google Scholar
• Gil, M. P. et al. Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function. Blood 120, 3718–3728 (2012).
  CAS PubMed PubMed Central Google Scholar
• Herbeuval, J. P. et al. Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc. Natl Acad. Sci. USA 103, 7000–7005 (2006).
  CAS PubMed Google Scholar
• Hardy, A. W., Graham, D. R., Shearer, G. M. & Herbeuval, J. P. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α. Proc. Natl Acad. Sci. USA 104, 17453–17458 (2007).
  CAS PubMed Google Scholar
• Herbeuval, J. P. et al. CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood 106, 3524–3531 (2005).
  CAS PubMed PubMed Central Google Scholar
• van Grevenynghe, J. et al. Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis. J. Clin. Invest. 121, 3877–3888 (2011).
  CAS PubMed PubMed Central Google Scholar
• Liedtke, C., Groger, N., Manns, M. P. & Trautwein, C. Interferon-α enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells. J. Hepatol. 44, 342–349 (2006).
  CAS PubMed Google Scholar
• Shigeno, M. et al. Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation. Oncogene 22, 1653–1662 (2003).
  CAS PubMed Google Scholar
• Toomey, N. L. et al. Induction of a TRAIL-mediated suicide program by interferon α in primary effusion lymphoma. Oncogene 20, 7029–7040 (2001).
  CAS PubMed Google Scholar
• Teijaro, J. R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207–211 (2013).
  CAS PubMed PubMed Central Google Scholar
• Wilson, E. B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202–207 (2013). References 128 and 129 were the first to show that type I IFNs contribute to pathogenesis by inducing suppressive mechanisms in chronic LCMV infection.
  CAS PubMed PubMed Central Google Scholar
• Herold, S. et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 205, 3065–3077 (2008).
  CAS PubMed PubMed Central Google Scholar
• Hogner, K. et al. Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 9, e1003188 (2013).
  PubMed PubMed Central Google Scholar
• Chaperot, L. et al. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J. Immunol. 176, 248–255 (2006).
  CAS PubMed Google Scholar
• Fujikura, D. et al. Type-I interferon is critical for FasL expression on lung cells to determine the severity of influenza. PLoS ONE 8, e55321 (2013).
  CAS PubMed PubMed Central Google Scholar
• McNally, B., Ye, F., Willette, M. & Flano, E. Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection. J. Virol. 87, 12916–12924 (2013).
  CAS PubMed PubMed Central Google Scholar
• Brincks, E. L. et al. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL. J. Immunol. 187, 4581–4588 (2011).
  CAS PubMed PubMed Central Google Scholar
• MacMicking, J. D. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nature Rev. Immunol. 12, 367–382 (2012).
  CAS Google Scholar
• Kazar, J., Gillmore, J. D. & Gordon, F. B. Effect of interferon and interferon inducers on infections with a nonviral intracellular microorganism, Chlamydia trachomatis. Infect. Immun. 3, 825–832 (1971).
  CAS PubMed PubMed Central Google Scholar
• de la Maza, L. M., Peterson, E. M., Goebel, J. M., Fennie, C. W. & Czarniecki, C. W. Interferon-induced inhibition of Chlamydia trachomatis: dissociation from antiviral and antiproliferative effects. Infect. Immun. 47, 719–722 (1985).
  CAS PubMed PubMed Central Google Scholar
• Ishihara, T. et al. Inhibition of Chlamydia trachomatis growth by human interferon-α: mechanisms and synergistic effect with interferon-γ and tumor necrosis factor-α. Biomed. Res. 26, 179–185 (2005).
  CAS PubMed Google Scholar
• Rothfuchs, A. G. et al. IFN-α/β-dependent, IFN-γ secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J. Immunol. 167, 6453–6461 (2001).
  CAS PubMed Google Scholar
• Rothfuchs, A. G. et al. STAT1 regulates IFN-αβ- and IFN-γ-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells. J. Immunol. 176, 6982–6990 (2006).
  CAS PubMed Google Scholar
• Qiu, H. et al. Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J. Immunol. 181, 2092–2102 (2008).
  CAS PubMed Google Scholar
• Opitz, B. et al. Legionella pneumophila induces IFNβ in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J. Biol. Chem. 281, 36173–36179 (2006).
  CAS PubMed Google Scholar
• Plumlee, C. R. et al. Interferons direct an effective innate response to Legionella pneumophila infection. J. Biol. Chem. 284, 30058–30066 (2009).
  CAS PubMed PubMed Central Google Scholar
• Schiavoni, G. et al. Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-γ-independent pathway. J. Immunol. 173, 1266–1275 (2004).
  CAS PubMed Google Scholar
• Gold, J. A. et al. Exogenous γ and α/β interferon rescues human macrophages from cell death induced by Bacillus anthracis. Infect. Immun. 72, 1291–1297 (2004).
  CAS PubMed PubMed Central Google Scholar
• Bukholm, G., Berdal, B. P., Haug, C. & Degre, M. Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect. Immun. 45, 62–66 (1984).
  CAS PubMed PubMed Central Google Scholar
• Niesel, D. W., Hess, C. B., Cho, Y. J., Klimpel, K. D. & Klimpel, G. R. Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. Infect. Immun. 52, 828–833 (1986).
  CAS PubMed PubMed Central Google Scholar
• Mancuso, G. et al. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J. Immunol. 178, 3126–3133 (2007).
  CAS PubMed Google Scholar
• Parker, D. et al. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio 2, e00016-11 (2011).
  PubMed PubMed Central Google Scholar
• Weigent, D. A., Huff, T. L., Peterson, J. W., Stanton, G. J. & Baron, S. Role of interferon in streptococcal infection in the mouse. Microb. Pathog. 1, 399–407 (1986).
  CAS PubMed Google Scholar
• Kelly-Scumpia, K. M. et al. Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J. Exp. Med. 207, 319–326 (2010).
  CAS PubMed PubMed Central Google Scholar
• Weighardt, H. et al. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J. Immunol. 177, 5623–5630 (2006).
  CAS PubMed Google Scholar
• Freudenberg, M. A. et al. A murine, IL-12-independent pathway of IFN-γ induction by Gram-negative bacteria based on STAT4 activation by type I IFN and IL-18 signaling. J. Immunol. 169, 1665–1668 (2002).
  CAS PubMed Google Scholar
• Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O'Riordan, M. & Portnoy, D. A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200, 527–533 (2004).
  CAS PubMed PubMed Central Google Scholar
• Carrero, J. A., Calderon, B. & Unanue, E. R. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 200, 535–540 (2004).
  CAS PubMed PubMed Central Google Scholar
• O'Connell, R. M. et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200, 437–445 (2004). References 155–157 were the first publications demonstrating an adverse effect of type I IFNs in intracellular infection with the bacterium L. monocytogenes.
  CAS PubMed PubMed Central Google Scholar
• Carrero, J. A., Calderon, B. & Unanue, E. R. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J. Exp. Med. 203, 933–940 (2006).
  CAS PubMed PubMed Central Google Scholar
• Stockinger, S. et al. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J. Immunol. 169, 6522–6529 (2002).
  CAS PubMed Google Scholar
• Zwaferink, H., Stockinger, S., Hazemi, P., Lemmens-Gruber, R. & Decker, T. IFN-β increases listeriolysin O-induced membrane permeabilization and death of macrophages. J. Immunol. 180, 4116–4123 (2008).
  CAS PubMed Google Scholar
• Zwaferink, H., Stockinger, S., Reipert, S. & Decker, T. Stimulation of inducible nitric oxide synthase expression by β interferon increases necrotic death of macrophages upon Listeria monocytogenes infection. Infect. Immun. 76, 1649–1656 (2008).
  CAS PubMed PubMed Central Google Scholar
• Dresing, P., Borkens, S., Kocur, M., Kropp, S. & Scheu, S. A fluorescence reporter model defines “Tip-DCs” as the cellular source of interferon β in murine listeriosis. PLoS ONE 5, e15567 (2010).
  CAS PubMed PubMed Central Google Scholar
• Stockinger, S. et al. Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes. PLoS Pathog. 5, e1000355 (2009).
  PubMed PubMed Central Google Scholar
• Rayamajhi, M., Humann, J., Penheiter, K., Andreasen, K. & Lenz, L. L. Induction of IFN-α/β enables Listeria monocytogenes to suppress macrophage activation by IFN-γ. J. Exp. Med. 207, 327–337 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kearney, S. J. et al. Type I IFNs downregulate myeloid cell IFN-γ receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription. J. Immunol. 191, 3384–3392 (2013).
  CAS PubMed PubMed Central Google Scholar
• Manca, C. et al. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 25, 694–701 (2005).
  CAS PubMed Google Scholar
• Ordway, D. et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179, 522–531 (2007).
  CAS PubMed Google Scholar
• Stanley, S. A., Johndrow, J. E., Manzanillo, P. & Cox, J. S. The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 178, 3143–3152 (2007).
  CAS PubMed Google Scholar
• Manca, C. et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β. Proc. Natl Acad. Sci. USA 98, 5752–5757 (2001). This study was the first demonstration of type I IFNs contributing to the exacerbation of tuberculosis in experimental mouse models.
  CAS PubMed Google Scholar
• Cooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S. & Orme, I. M. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68, 6879–6882 (2000).
  CAS PubMed PubMed Central Google Scholar
• Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973–977 (2010). This study provided the first evidence that type I IFN-mediated signalling is associated with active tuberculosis in humans.
  CAS PubMed PubMed Central Google Scholar
• Cliff, J. M. et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J. Infect. Dis. 207, 18–29 (2013).
  CAS PubMed Google Scholar
• Maertzdorf, J. et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun. 12, 15–22 (2011).
  CAS PubMed Google Scholar
• Ottenhoff, T. H. et al. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS ONE 7, e45839 (2012).
  CAS PubMed PubMed Central Google Scholar
• Antonelli, L. R. et al. Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120, 1674–1682 (2010).
  CAS PubMed PubMed Central Google Scholar
• Mayer-Barber, K. D. et al. Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35, 1023–1034 (2011).
  CAS PubMed PubMed Central Google Scholar
• McNab, F. W. et al. TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production. J. Immunol. 191, 1732–1743 (2013).
  CAS PubMed PubMed Central Google Scholar
• Redford, P. S. et al. Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J. Infect. Dis. 209, 270–274 (2014).
  CAS PubMed Google Scholar
• Mayer-Barber, K. D. et al. Caspase-1 independent IL-1β production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326–3330 (2010).
  CAS PubMed PubMed Central Google Scholar
• de Paus, R. A. et al. Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β. Cytokine 61, 645–655 (2013).
  CAS PubMed Google Scholar
• Novikov, A. et al. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages. J. Immunol. 187, 2540–2547 (2011).
  CAS PubMed PubMed Central Google Scholar
• McNab, F. W. et al. Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in _Mycobacterium tuberculosis_-infected macrophages. J. Immunol. 193, 3600–3612 (2014). This key study demonstrates the mechanisms underlying the adverse effects of type I IFNs in tuberculosis, including blocking of the protective type II IFN action, as well as blocking of IL-12, IL-1 and TNF production, in part through IL-10 induction.
  CAS PubMed PubMed Central Google Scholar
• Guarda, G. et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34, 213–223 (2011). This was the first study to show inhibition of the inflammasome by type I IFNs.
  CAS PubMed Google Scholar
• Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99–103 (2014). This seminal study shows the counter-regulatory function of IL-1 and type I IFNs in controlling the outcome of M. tuberculosis infection via eicosanoids.
  CAS PubMed PubMed Central Google Scholar
• Xu, X. J., Reichner, J. S., Mastrofrancesco, B., Henry, W. L. Jr & Albina, J. E. Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-β production. J. Immunol. 180, 2125–2131 (2008). This study provided the first demonstration that prostaglandin E2 suppresses lipopolysaccharide-stimulated IFNβ production.
  CAS PubMed Google Scholar
• Coulombe, F. et al. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. Immunity 40, 554–568 (2014).
  CAS PubMed Google Scholar
• Teles, R. M. et al. Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339, 1448–1453 (2013). In this key study, a mechanism is reported for type I IFN-mediated blocking of the protective role of type II IFN in tuberculosis.
  CAS PubMed PubMed Central Google Scholar
• Desvignes, L., Wolf, A. J. & Ernst, J. D. Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J. Immunol. 188, 6205–6215 (2012). This important study shows that type I IFNs contribute to protection against M. tuberculosis when type II IFN-mediated signalling is aberrant.
  CAS PubMed PubMed Central Google Scholar
• Bogunovic, D. et al. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science 337, 1684–1688 (2012).
  CAS PubMed PubMed Central Google Scholar
• Mariotti, S. et al. Mycobacterium tuberculosis diverts α interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells. Infect. Immun. 72, 4385–4392 (2004).
  CAS PubMed PubMed Central Google Scholar
• Fernandes-Alnemri, T. et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nature Immunol. 11, 385–393 (2010).
  CAS Google Scholar
• Henry, T., Brotcke, A., Weiss, D. S., Thompson, L. J. & Monack, D. M. Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J. Exp. Med. 204, 987–994 (2007).
  CAS PubMed PubMed Central Google Scholar
• Henry, T. et al. Type I IFN signaling constrains IL-17A/F secretion by γδ T cells during bacterial infections. J. Immunol. 184, 3755–3767 (2010).
  CAS PubMed PubMed Central Google Scholar
• Shah, S. et al. Mycobacterium tuberculosis but not nonvirulent mycobacteria inhibits IFN-β and AIM2 inflammasome-dependent IL-1β production via its ESX-1 secretion system. J. Immunol. 191, 3514–3518 (2013).
  CAS PubMed PubMed Central Google Scholar
• Al Moussawi, K. et al. Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei. PLoS Pathog. 6, e1000722 (2010).
  PubMed PubMed Central Google Scholar
• de Almeida, L. A. et al. MyD88 and STING signaling pathways are required for IRF3-mediated IFN-β induction in response to Brucella abortus infection. PLoS ONE 6, e23135 (2011).
  CAS PubMed PubMed Central Google Scholar
• Patel, A. A., Lee-Lewis, H., Hughes-Hanks, J., Lewis, C. A. & Anderson, D. M. Opposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plague. PLoS Pathog. 8, e1002817 (2012).
  CAS PubMed PubMed Central Google Scholar
• Robinson, N. et al. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nature Immunol. 13, 954–962 (2012).
  CAS Google Scholar
• Rathinam, V. A. et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by Gram-negative bacteria. Cell 150, 606–619 (2012).
  CAS PubMed PubMed Central Google Scholar
• Broz, P. et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490, 288–291 (2012).
  CAS PubMed PubMed Central Google Scholar
• Martin, F. J. et al. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J. Clin. Invest. 119, 1931–1939 (2009).
  CAS PubMed PubMed Central Google Scholar
• Diefenbach, A. et al. Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8, 77–87 (1998).
  CAS PubMed Google Scholar
• Mattner, J. et al. Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major. Eur. J. Immunol. 30, 2257–2267 (2000).
  CAS PubMed Google Scholar
• Mattner, J. et al. Protection against progressive leishmaniasis by IFN-β. J. Immunol. 172, 7574–7582 (2004).
  CAS PubMed Google Scholar
• Khouri, R. et al. IFN-β impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J. Immunol. 182, 2525–2531 (2009).
  CAS PubMed Google Scholar
• Xin, L. et al. Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites. J. Immunol. 184, 7047–7056 (2010).
  CAS PubMed PubMed Central Google Scholar
• Haque, A. et al. Type I interferons suppress CD4+ T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur. J. Immunol. 41, 2688–2698 (2011).
  CAS PubMed Google Scholar
• Vigario, A. M. et al. Inhibition of Plasmodium yoelii blood-stage malaria by interferon α through the inhibition of the production of its target cell, the reticulocyte. Blood 97, 3966–3971 (2001).
  CAS PubMed Google Scholar
• Vigario, A. M. et al. Recombinant human IFN-α inhibits cerebral malaria and reduces parasite burden in mice. J. Immunol. 178, 6416–6425 (2007).
  CAS PubMed Google Scholar
• Voisine, C., Mastelic, B., Sponaas, A. M. & Langhorne, J. Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria. Int. J. Parasitol. 40, 711–719 (2010).
  CAS PubMed Google Scholar
• Liehl, P. et al. Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection. Nature Med. 20, 47–53 (2014).
  CAS PubMed Google Scholar
• Costa, V. M. et al. Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J. Immunol. 177, 3193–3200 (2006).
  CAS PubMed Google Scholar
• Koga, R. et al. TLR-dependent induction of IFN-β mediates host defense against Trypanosoma cruzi. J. Immunol. 177, 7059–7066 (2006).
  CAS PubMed Google Scholar
• Lopez, R., Demick, K. P., Mansfield, J. M. & Paulnock, D. M. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. J. Immunol. 181, 4908–4917 (2008).
  CAS PubMed PubMed Central Google Scholar
• Chessler, A. D., Caradonna, K. L., Da'dara, A. & Burleigh, B. A. Type I interferons increase host susceptibility to Trypanosoma cruzi infection. Infect. Immun. 79, 2112–2119 (2011).
  CAS PubMed PubMed Central Google Scholar
• Une, C., Andersson, J. & Orn, A. Role of IFN-α/β and IL-12 in the activation of natural killer cells and interferon-γ production during experimental infection with Trypanosoma cruzi. Clin. Exp. Immunol. 134, 195–201 (2003).
  CAS PubMed PubMed Central Google Scholar
• Biondo, C. et al. IFN-α/β signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis. J. Immunol. 181, 566–573 (2008).
  CAS PubMed Google Scholar
• Biondo, C. et al. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. Eur. J. Immunol. 41, 1969–1979 (2011).
  CAS PubMed Google Scholar
• del Fresno, C. et al. Interferon-β production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38, 1176–1186 (2013).
  CAS PubMed Google Scholar
• Majer, O. et al. Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathog. 8, e1002811 (2012).
  CAS PubMed PubMed Central Google Scholar
• Bourgeois, C. et al. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-β signaling. J. Immunol. 186, 3104–3112 (2011).
  CAS PubMed Google Scholar
• Inglis, D. O., Berkes, C. A., Hocking Murray, D. R. & Sil, A. Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages. Infect. Immun. 78, 3871–3882 (2010).
  CAS PubMed PubMed Central Google Scholar
• Liu, L. et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635–1648 (2011).
  CAS PubMed PubMed Central Google Scholar
• van de Veerdonk, F. L. et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365, 54–61 (2011).
  CAS PubMed Google Scholar
• Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962–970 (2008).
  PubMed PubMed Central Google Scholar
• Li, W., Moltedo, B. & Moran, T. M. Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells. J. Virol. 86, 12304–12312 (2012).
  CAS PubMed PubMed Central Google Scholar
• Nakamura, S., Davis, K. M. & Weiser, J. N. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Invest. 121, 3657–3665 (2011).
  CAS PubMed PubMed Central Google Scholar
• Shahangian, A. et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 119, 1910–1920 (2009).
  CAS PubMed PubMed Central Google Scholar
• Tian, X. et al. Poly I:C enhances susceptibility to secondary pulmonary infections by Gram-positive bacteria. PLoS ONE 7, e41879 (2012).
  CAS PubMed PubMed Central Google Scholar
• Navarini, A. A. et al. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc. Natl Acad. Sci. USA 103, 15535–15539 (2006).
  CAS PubMed Google Scholar
• Kim, Y. G. et al. Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host Microbe 9, 496–507 (2011).
  CAS PubMed PubMed Central Google Scholar
• Belkaid, Y. & Hand, T. W. Role of the microbiota in immunity and inflammation. Cell 157, 121–141 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ganal, S. C. et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 37, 171–186 (2012).
  CAS PubMed Google Scholar
• Abt, M. C. et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37, 158–170 (2012).
  CAS PubMed PubMed Central Google Scholar
• Tschurtschenthaler, M. et al. Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regeneration. Gut 63, 1921–1931 (2014).
  CAS PubMed Google Scholar
• Kawashima, T. et al. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β. Immunity 38, 1187–1197 (2013). This study shows that the microbiota contributes to the initial production of protective type I IFNs. References 235 and 236 collectively demonstrate a novel interplay between the microbiota, type I IFNs and consequent protection against pathogens.
  CAS PubMed Google Scholar
• Gough, D. J., Messina, N. L., Clarke, C. J., Johnstone, R. W. & Levy, D. E. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36, 166–174 (2012).
  CAS PubMed PubMed Central Google Scholar